Posts
Why UniQure's Etranacogene dezaparvovec Gene Therapy Still Holds A Promise For Hemophilia B Patients With Unmet Medical Needs
Why UniQure's Etranacogene dezaparvovec Gene Therapy Still Holds A Promise For Hemophilia B Patients With Unmet Medical Needs
- Get link
- Other Apps
Uniqure hemophilia B gene therapy program On Clinical hold by the U.S. Food and Drug Administration (FDA)
Uniqure hemophilia B gene therapy program On Clinical hold by the U.S. Food and Drug Administration (FDA)
- Get link
- Other Apps
- Get link
- Other Apps
- Get link
- Other Apps
- Get link
- Other Apps
Orchard Therapeutics: European Medicines Approves Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
Orchard Therapeutics: European Medicines Approves Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
- Get link
- Other Apps
Orchard Therapeutics: Clinical Study on Gene Therapy With Modified Autologous Hematopoietic Stem Cells for Patients With Mucopolysaccharidosis Type IIIA
Orchard Therapeutics: Clinical Study on Gene Therapy With Modified Autologous Hematopoietic Stem Cells for Patients With Mucopolysaccharidosis Type IIIA
- Get link
- Other Apps
Bluebird Bio's: Lentiglobulin Infusion Showed Durable Expression of Modified Form Functional Beta-Globin in Sickle Cell Disease
Bluebird Bio's: Lentiglobulin Infusion Showed Durable Expression of Modified Form Functional Beta-Globin in Sickle Cell Disease
- Get link
- Other Apps
CTX001: CRISPR Therapeutics and Vertex Present Positive Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies
CTX001: CRISPR Therapeutics and Vertex Present Positive Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies
- Get link
- Other Apps
- Get link
- Other Apps
- Get link
- Other Apps
- Get link
- Other Apps
- Get link
- Other Apps
- Get link
- Other Apps
- Get link
- Other Apps
- Get link
- Other Apps
- Get link
- Other Apps
- Get link
- Other Apps